Marc Zabeau

Last updated

Marc Zabeau (born 1949, Lier, Belgium) is a Belgian scientist and businessman.

Contents

Biography

Marc Zabeau graduated in 1971 as a licentiate in zoology at the University of Ghent and obtained a PhD in 1974, studying the genetics of Escherichia coli in the lab of Jeff Schell.

In 1976, on an NFWO scholarship as a Fulbright Hayes postdoctoral fellow, he went for two years to the Cold Spring Harbor Laboratory in New York, the United States. From 1978 until 1983 he worked at the European Molecular Biology Laboratory in Heidelberg, Germany. during his stay in Heidelberg, he was appointed as professor of genetic engineering at the Vrije Universiteit Brussel.

In 1983, he became director of research of Plant Genetic Systems in Ghent, Belgium and in 1986 director of intellectual property and business development. He founded several biotech companies, such as Helix C.V. (Ghent, 1988), KeyGene N.V. (Wageningen, 1989), GenScope Inc. (United States, 1995) and Methexis (Ghent, 1997). In 1999, he succeeded Marc Van Montagu as scientific director of the Department of Plant Systems Biology at the Flanders Institute for Biotechnology (VIB). In 2002, he was succeeded by Dirk Inzé. In 1999, he was appointed as full-time professor of genome biology and functional genomics at the University of Ghent.

Zabeau was formerly CEO of Trinean. [1]

He is currently managing partner of Qbic Venture Partners. [2]

Selected publications

Related Research Articles

<span class="mw-page-title-main">Cold Spring Harbor Laboratory</span> Private, non-profit research institution in US

Cold Spring Harbor Laboratory (CSHL) is a private, non-profit institution with research programs focusing on cancer, neuroscience, plant biology, genomics, and quantitative biology. It is located in Laurel Hollow on Long Island, New York.

Elliot Meyerowitz is an American biologist.

<span class="mw-page-title-main">Vlaams Instituut voor Biotechnologie</span>

VIB is a research institute located in Flanders, Belgium. It was founded by the Flemish government in 1995, and became a full-fledged institute on 1 January 1996. The main objective of VIB is to strengthen the excellence of Flemish life sciences research and to turn the results into new economic growth. VIB spends almost 80% of its budget on research activities, while almost 12% is spent on technology transfer activities and stimulating the creation of new businesses, in addition VIB spends approximately 2% on socio-economic activities. VIB is member of EU-LIFE, an alliance of leading life sciences research centres in Europe.

Walter Fiers was a Belgian molecular biologist.

<span class="mw-page-title-main">Jozef Schell</span> Belgian molecular biologist

Jozef Stefaan "Jeff", Baron Schell was a Belgian molecular biologist.

<span class="mw-page-title-main">Marc Van Montagu</span> Belgian molecular biologist

Marc, Baron Van Montagu is a Belgian molecular biologist. He was full professor and director of the Laboratory of Genetics at the faculty of Sciences at Ghent University (Belgium) and scientific director of the genetics department of the Flanders Interuniversity Institute for Biotechnology (VIB). Together with Jozef Schell he founded the biotech company Plant Genetic Systems Inc. (Belgium) in 1982, of which he was scientific director and member of the board of directors. Van Montagu was also involved in founding the biotech company CropDesign, of which he was a board member from 1998 to 2004. He is president of the Public Research and Regulation Initiative (PRRI).

<span class="mw-page-title-main">Plant Genetic Systems</span> Bayer Subsidiary

Plant Genetic Systems (PGS), since 2002 part of Bayer CropScience, is a biotech company located in Ghent, Belgium. The focus of its activities is the genetic engineering of plants. The company is best known for its work in the development of insect-resistant transgenic plants.

Dirk Inzé is a Belgian molecular biologist and professor at Ghent University. In 2002, he succeeded Marc Zabeau as scientific director of the VIB-UGent Center for Plant Systems Biology. His research interest is on the molecular networks underpinning yield and organ growth both under standard as well as mild drought stress conditions in Arabidopsis and the C4 crop maize. He is a member of the European Molecular Biology Organization (EMBO). He was recipient of the 1994 Körber European Science Prize. In 2005, he was awarded the Francqui Prize on Biological and Medical Sciences for his research on plant systems biology.

<span class="mw-page-title-main">David Baulcombe</span> British plant scientist and geneticist

Sir David Charles Baulcombe is a British plant scientist and geneticist. As of 2017 he is a Royal Society Research Professor. From 2007 to 2020 he was Regius Professor of Botany in the Department of Plant Sciences at the University of Cambridge.

Ann Van Gysel is a Belgian scientist and CEO of MEDVIA, a healthcare cluster that supports innovation in Flanders, Belgium.

<span class="mw-page-title-main">History of genetic engineering</span>

Genetic engineering is the science of manipulating genetic material of an organism. The first artificial genetic modification accomplished using biotechnology was transgenesis, the process of transferring genes from one organism to another, first accomplished by Herbert Boyer and Stanley Cohen in 1973. It was the result of a series of advancements in techniques that allowed the direct modification of the genome. Important advances included the discovery of restriction enzymes and DNA ligases, the ability to design plasmids and technologies like polymerase chain reaction and sequencing. Transformation of the DNA into a host organism was accomplished with the invention of biolistics, Agrobacterium-mediated recombination and microinjection. The first genetically modified animal was a mouse created in 1974 by Rudolf Jaenisch. In 1976 the technology was commercialised, with the advent of genetically modified bacteria that produced somatostatin, followed by insulin in 1978. In 1983 an antibiotic resistant gene was inserted into tobacco, leading to the first genetically engineered plant. Advances followed that allowed scientists to manipulate and add genes to a variety of different organisms and induce a range of different effects. Plants were first commercialized with virus resistant tobacco released in China in 1992. The first genetically modified food was the Flavr Savr tomato marketed in 1994. By 2010, 29 countries had planted commercialized biotech crops. In 2000 a paper published in Science introduced golden rice, the first food developed with increased nutrient value.

<span class="mw-page-title-main">Gloria M. Coruzzi</span> American biologist

Gloria M. Coruzzi is an American molecular biologist specializing in plant systems biology and evolutionary genomics.

Ekkehard Karl Friedrich Bautz is a molecular biologist and chair of the Institute of Molecular Genetics at the University of Heidelberg.

<span class="mw-page-title-main">Fred Sherman (scientist)</span> American geneticist

Fred Sherman was an American scientist who pioneered the use of the budding yeast Saccharomyces cerevisiae as a model for studying the genetics, molecular biology, and biochemistry of eukaryotic cells. His research encompassed broad areas of yeast biology including gene expression, protein synthesis, messenger RNA processing, bioenergetics, and mechanisms of mutagenesis. He also contributed extensively to the genetics of the opportunistic pathogen Candida albicans.

Michael Webster Bevan is a professor at the John Innes Centre, Norwich, UK.

Robert Anthony Martienssen is a British plant biologist, Howard Hughes Medical Institute–Gordon and Betty Moore Foundation investigator, and professor at Cold Spring Harbor Laboratory, US.

<span class="mw-page-title-main">Ian A. Graham</span> British biologist (born 1963)

Ian Alexander Graham is a professor of Biochemical Genetics in the Centre for Novel Agricultural Products (CNAP) at the University of York.

Patrick Charnay is a French biologist, researcher. Serving as an Emeritus research director for Inserm, he works and teaches in molecular genetics and development biology at the École normale supérieure (ENS) in Paris.

<span class="mw-page-title-main">Anthony Cashmore</span> New Zealand molecular biologist

Anthony R. Cashmore is a biochemist and plant molecular biologist, best known for identifying cryptochrome photoreceptor proteins. These specialized proteins are critical for plant development and play an essential role in circadian rhythms of plants and animals. A Professor emeritus in the Department of Biology at the University of Pennsylvania, Cashmore led the Plant Science Institute from the time of his appointment in 1986 until his retirement in 2011. He was elected to the National Academy of Sciences in 2003.

Michel Delseny is director of research emeritus at the CNRS and a member of the French Academy of sciences.

References

  1. Archived 31 October 2017 at the Wayback Machine
  2. "Marc Zabeau - Team - Qbic". Qbic.be. Retrieved 13 July 2018.

Sources